Previous 10 | Next 10 |
2023-09-01 19:55:44 ET Summary Assertio's Q2 earnings report showed a 16.7% annual growth in revenue, exceeding forecasts by $1.16M. The company's profitability and liquidity are promising, with a positive operating cash flow and substantial cash on hand. Assertio faces a sign...
Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the release of a thematic report that examines small market cap pharmaceutical companies based on revenue growth and valuation. The report: Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline ex...
2023-08-07 10:15:28 ET Gainers: Poseida Therapeutics ( PSTX ) +33% . Tabula Rasa HealthCare ( TRHC ) +32% . Mallinckrodt plc ( MNK ) +17% . Assertio Holdings ( ASRT ) +18% . Palatin Technologies ( PTN ) +16% . Losers: Sag...
2023-08-04 10:09:12 ET Gainers: Alector ( ALEC ) +22% . OraSure Technologies ( OSUR ) +21% . Amneal Pharmaceuticals ( AMRX ) +20% . iRhythm Technologies ( IRTC ) +20% . Natera ( NTRA ) +16% . Losers: Mesoblast ( MESO ) ...
2023-08-03 20:18:09 ET Assertio Holdings Inc. (ASRT) Q2 2023 Earnings Call Transcript August 03, 2023 4:30 PM ET Company Participants Matt Kreps - Investor Relations Dan Peisert - President and CEO Paul Schwichtenberg - Senior Vice President and CFO Tom Riga ...
2023-08-03 16:38:58 ET Assertio Holdings press release ( NASDAQ: ASRT ): Q2 Non-GAAP EPS of $0.19 misses by $0.03 . Revenue of $40.99M (+16.7% Y/Y) beats by $1.16M . For further details see: Assertio Holdings Non-GAAP EPS of $0.19 misses by $0.03, revenue...
Second Quarter Net Product Sales Increase 13% Year-Over-Year, Generates $18.6 Million in Cash Flow from Operations Acquisition Expected to be Significantly Accretive to Adjusted EPS in 2024 LAKE FOREST, Ill., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, ...
Combination of Assertio’s Omni-Channel Digital Sales Capabilities and ROLVEDON In-Person Commercial Team to Enhance Market Access and Growth Across All Products Transaction Expected to be Significantly Accretive to Assertio in 2024 LAKE FOREST, Ill., July 31, 2023 (GLOBE NE...
2023-07-27 16:16:34 ET Assertio Holdings Inc ( NASDAQ: ASRT ) on Thursday announced favorable vote on proposed acquisition of Spectrum Pharmaceuticals Inc ( SPPI ). “We believe this transaction provides extensive new growth opportunities and will be accretive to our...
Stockholders From Both Assertio and Spectrum Have Overwhelmingly Voted in Support of the Transaction Transaction Expected to be Significantly Accretive to Assertio in 2024 LAKE FOREST, Ill. and BOSTON, July 27, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertioȁ...
News, Short Squeeze, Breakout and More Instantly...
Assertio Therapeutics Inc. Company Name:
ASRT Stock Symbol:
NASDAQ Market:
Assertio Therapeutics Inc. Website:
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ASRT on July 3, 2024 06:04AM ET. ASRT was trading at $1.15 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief...
LAKE FOREST, Ill., May 29, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that its Board of...